Expression of toll-like receptor 9 and response to bacterial cpg oligodeoxynucleotides in human intestinal epithelium

Clinical and Experimental Immunology

Volumn 141, Issue 2, 2005, Pages 298-306

  Andresen, L ^a   Matthiessen, M W ^a   Rask Madsen, J ^a   Brynskov, J ^a   Pedersen, Gitte ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Inflammatory bowel disease; Interleukin 8; Intestinal epithelial cell; Oligonucleotides; Toll like receptor

Indexed keywords

BACTERIAL DNA; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; GENOMIC DNA; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CPG ISLAND; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELLS, CULTURED; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 22344440495     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02848.x     Document Type: Article

References (49)

1. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85:85-95.
2. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-7.
3. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80.
4. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7.
5. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001; 166:2018-24.
6. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
7. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-7.
8. Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J Immunol 2001; 166:2372-7.
9. Klinman DM, Takeshita F, Gursel I et al. CpG DNA: recognition by and activation of monocytes. Microbes Infect 2002; 4:897-901.
10. Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000; 164:944-53.
11. Chu W, Gong X, Li Z et al. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 2000; 103:909-18.
12. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41.
13. Strober W, Fuss IJ, Nakamura K, Kitani A. Recent advances in the understanding of the induction and regulation of mucosal inflammation. J Gastroenterol 2003; 38 (Suppl. 15):55-8.
14. Strober W. Epithelial cells pay a Toll for protection. Nat Med 2004; 10:898-900.
15. Obermeier F, Dunger N, Demi L, Herfarth H, Scholmerich J, Falk W. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol 2002; 32:2084-92.
16. Kobayashi M, Kweon MN, Kuwata H et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest 2003; 111:1297-308.
17. Obermeier F, Dunger N, Strauch UG et al. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol 2003; 134:217-24.
18. Rachmilewitz D, Karmeli F, Takabayashi K et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002; 122:1428-41.
19. Rachmilewitz D, Katakura K, Karmeli K et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-8.
20. Sartor RB. Innate immunity in the pathogenesis and therapy of IBD. J Gastroenterol 2003; 38 (Suppl. 15):43-7.
21. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000; 164:966-72.
22. Gibson PR. Ulcerative colitis: an epithelial disease? Bailliéres Clin Gastroenterol 1997; 11:17-33.
23. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126:1054-70.
24. Berrebi D, Maudinas R, Hugot JP et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003; 52:840-6.
25. Rosenstiel P, Fantini M, Brautigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124:1001-9.
26. Pedersen G, Saermark T, Giese B, Hansen A, Drag B, Brynskov J. A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity. Scand J Gastroenterol 2000; 35:772-80.
27. Pedersen G, Saermark T, Bendtzen K, Brynskov J. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFN-gamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion. Autoimmunity 2000; 32:255-63.
28. Brynskov J, Foegh P, Pedersen G et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 2002; 51:37-43.
29. Nielsen OH, Bouchelouche PN, Berild D, Ahnfelt-Ronne I. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes. Scand J Gastroenterol 1993; 28:527-32.
30. Takeshita F, Leifer CA, Gursel I et al. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001; 167:3555-8.
31. Hartmann G, Weiner GJ, Krieg AM. CpGDNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999; 96:9305-10.
32. Eckmann L, Kagnoff MF, Falco MT. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994; 82:505.
33. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 2001; 32:449-53.
34. Hausmann M, Kiessling S, Mestermann S et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002; 122:1987-2000.
35. Abreu MT, Arnold ET, Thomas LS et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002; 277:20431-7.
36. Schmausser B, Andrulis M, Endrich S et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136:521-6.
37. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997; 100:6-10.
38. Akhtar M, Watson JL, Nazli A, McKay DM. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathway. FASEB J 2003; 17:1319-21.
39. Jobin C, Sartor RB. The IκB/NF-κB system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol 2000; 278:C451-62.
40. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002; 30:S1-11.
41. Melmed G, Thomas LS, Lee N et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003; 170:1406-15.
42. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004; 127:224-38.
43. Zou W, Amcheslavsky A, Bar-Shavit Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 2003; 278:16732-40.
44. Gibson PR, Moeller I, Kagelari O, Folino M, Young GP. Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J Gastroenterol Hepatol 1992; 7:165-72.
45. Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, Gibson PR. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 2001; 120:889-99.
46. Gibson PR, Rosella O, Wilson AJ et al. Colonic epithelial cell activation and the paradoxical effects of butyrate. Carcinogenesis 1999; 20:539-44.
47. Vollmer J, Weeratna RD, Jurk M et al. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity. J Leukoc Biol 2004; 76:585-93.
48. Ballas ZK, Krieg AM, Warren T et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 2001; 167:4878-86.
49. Zhang G, Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 2002; 277:7059-65.